Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' FARINOTTI R' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 105 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Baud-Camus, F; Marquet, P; Soursac, M; Davrinche, C; Farinotti, R
      Determination of N-acetylation phenotype using caffeine as a metabolic probe and high-performance liquid chromatography with either ultraviolet detection or electrospray mass spectrometry

      JOURNAL OF CHROMATOGRAPHY B
    2. Veau, C; Leroy, C; Banide, H; Auchere, D; Tardivel, S; Farinotti, R; Lacour, B
      Effect of chronic renal failure on the expression and function of rat intestinal P-glycoprotein in drug excretion

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    3. Hiep, BT; Fernandez, C; Tod, M; Banide, H; Thuillier, A; Lacour, B; Farinotti, R; Gimenez, F
      Intestinal absorption and metabolism of chlorpheniramine enantiomers in rat

      CHIRALITY
    4. Forestier, F; de Renty, P; Peytavin, G; Dohin, E; Farinotti, R; Mandelbrot, L
      Maternal-fetal transfer of saquinavir studied in the ex vivo placental perfusion model

      AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
    5. Mandelbrot, L; Peytavin, G; Firtion, G; Farinotti, R
      Maternal-fetal transfer and amniotic fluid accumulation of lamivudine in human immunodeficiency virus-infected pregnant women

      AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
    6. Hiep, B; Fernandez, C; Khanh, V; Hung, NK; Thuillier, A; Farinotti, R; Arnaud, P; Gimenez, F
      Stereospecific versus nonstereospecific assessments for the bioequivalenceof two formulations of racemic chlorpheniramie

      CHIRALITY
    7. Joly-Guillou, ML; Wolff, M; Farinotti, R; Bryskier, A; Carbon, C
      In vivo activity of levofloxacin alone or in combination with imipenem or amikacin in a mouse model of Acinetobacter baumannii pneumonia

      Journal of antimicrobial chemotherapy
    8. Pham, YT; Regina, A; Farinotti, R; Couraud, PO; Wainer, IW; Roux, F; Gimenez, F
      Interactions of racemic mefloquine and its enantiomers with P-glycoproteinin an immortalised rat brain capillary endothelial cell line, GPNT

      BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
    9. Aboubakar, M; Couvreur, P; Pinto-Alphandary, H; Gouritin, B; Lacour, B; Farinotti, R; Puisieux, F; Vauthier, C
      Insulin-loaded nanocapsules for oral administration: In vitro and in vivo investigation

      DRUG DEVELOPMENT RESEARCH
    10. Berlioz, F; Lepere-Prevot, B; Julien, S; Tsocas, A; Carbon, C; Roze, C; Farinotti, R
      Chronic nifedipine dosing enhances cephalexin bioavailability and intestinal absorption in conscious rats

      DRUG METABOLISM AND DISPOSITION
    11. Duval, X; Le Moing, V; Longuet, P; Leport, C; Vilde, JL; Lamotte, C; Peytavin, G; Farinotti, R
      Efavirenz induced decrease in plasma amprenavir levels in human immunodeficiency virus-infected patients and correction by ritonavir

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    12. Berlioz, F; Maoret, JJ; Paris, H; Laburthe, M; Farinotti, R; Roze, C
      alpha(2)-adrenergic receptors stimulate oligopeptide transport in a human intestinal cell line

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    13. Peytavin, G; Leng, JJ; Forestier, F; Saux, MC; Hohlfeld, P; Farinotti, R
      Placental transfer of pyrimethamine studied in an ex vivo placental perfusion model

      BIOLOGY OF THE NEONATE
    14. Lamotte, C; Peytavin, G; Farinotti, R
      Determination of nelfinavir, a potent HIV protease inhibitor, and its active metabolite M8 in human plasma by high-performance liquid chromatography with photodiode-array detection

      JOURNAL OF CHROMATOGRAPHY B
    15. Pham, YT; Nosten, F; Farinotti, R; White, NJ; Gimenez, F
      Cerebral uptake of mefloquine enantiomers in fatal cerebral malaria

      INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
    16. Hiep, BT; Gimenez, F; Khanh, V; Hung, NK; Thuillier, A; Farinotti, R; Fernandez, C
      Binding of chlorpheniramine enantiomers to human plasma proteins

      CHIRALITY
    17. Fernandez, C; Gimenez, F; Thuillier, A; Farinotti, R
      Stereoselective binding of zopiclone to human plasma proteins

      CHIRALITY
    18. Castela-Papin, N; Cai, S; Vatier, J; Keller, F; Souleau, CH; Farinotti, R
      Drug interactions with diosmectite: a study using the artificial stomach-duodenum model

      INTERNATIONAL JOURNAL OF PHARMACEUTICS
    19. Papin-Castela, N; Prognon, P; Keller, F; Benazeth, S; Farinotti, R; Mahuzier, G; Souleau, C
      Cerium-doped diosmectite for topical application studies of the cerium-clay interaction

      INTERNATIONAL JOURNAL OF PHARMACEUTICS
    20. Baune, B; Furlan, V; Taburet, AM; Farinotti, R
      Effect of selected antimalarial drugs and inhibitors of cytochrome P-450 3A4 on halofantrine metabolism by human liver microsomes

      DRUG METABOLISM AND DISPOSITION
    21. Wolff, M; Joly-Guillou, ML; Farinotti, R; Carbon, C
      In vivo efficacies of combinations of beta-lactams, beta-lactamase inhibitors, and rifampin against Acinetobacter baumannii in a mouse pneumonia model

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    22. Dautrey, S; Rabbaa, L; Laouari, D; Lacour, B; Carbon, C; Farinotti, R
      Influence of renal failure on intestinal clearance of ciprofloxacin in rats

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    23. Nascimbeni, M; Lamotte, C; Peytavin, G; Farinotti, R; Clavel, F
      Kinetics of antiviral activity and intracellular pharmacokinetics of humanimmunodeficiency virus type 1 protease inhibitors in tissue culture

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    24. Baune, B; Furlan, V; Taburet, AM; Farinotti, R
      In vitro effects of racemates, separate enantiomers and major metabolites of mefloquine and halofantrine on metoprolol biotransformation by rat livermicrosomes

      XENOBIOTICA
    25. Baune, B; Flinois, JP; Furlan, V; Gimenez, F; Taburet, AM; Becquemont, L; Farinotti, R
      Halofantrine metabolism in microsomes in man: Major role of CYP 3A4 and CYP 3A5

      JOURNAL OF PHARMACY AND PHARMACOLOGY
    26. Berlioz, F; Julien, S; Tsocas, A; Chariot, J; Carbon, C; Farinotti, R; Roze, C
      Neural modulation of cephalexin intestinal absorption through the di- and tripeptide brush border transporter of rat jejunum in vivo

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    27. Dautrey, S; Felice, K; Petiet, A; Lacour, B; Carbon, C; Farinotti, R
      Active intestinal elimination of ciprofloxacin in rats: modulation by different substrates

      BRITISH JOURNAL OF PHARMACOLOGY
    28. IGLARZ M; BAUNE B; GANTIER JC; HOCQUEMILLER R; FARINOTTI R
      DETERMINATION OF 2-N-PROPYLQUINOLINE IN MOUSE PLASMA AND LIVER BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY

      Journal of chromatography B. Biomedical sciences and applications
    29. GORICHON E; MARTIN C; BANGCHANG KN; KARBWANG J; THUILLIER A; FARINOTTI R; GIMENEZ F
      CHIRAL CHROMATOGRAPHIC METHOD TO DETERMINE THE ENANTIOMERS OF HALOFANTRINE AND ITS MAIN CHIRAL DESBUTYL METABOLITE IN ERYTHROCYTES

      Journal of chromatography B. Biomedical sciences and applications
    30. CHENEVIER P; MASSIAS L; GUEYLARD D; FARINOTTI R
      DETERMINATION OF ETHAMBUTOL IN PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY AFTER PRECOLUMN DERIVATIZATION

      Journal of chromatography B. Biomedical sciences and applications
    31. DEROUIN F; GERARD L; FARINOTTI R; MASLO C; LEPORT C
      DETERMINATION OF THE INHIBITORY EFFECT ON TOXOPLASMA GROWTH IN THE SERUM OF AIDS PATIENTS DURING ACUTE THERAPY FOR TOXOPLASMIC ENCEPHALITIS

      Journal of acquired immune deficiency syndromes and human retrovirology
    32. VATIER J; CELICEPINGAUD C; FARINOTTI R
      INTERESTS OF THE ARTIFICIAL STOMACH TECHNIQUES TO STUDY ANTACID FORMULATIONS - COMPARISON WITH IN-VIVO EVALUATION

      Fundamental and clinical pharmacology
    33. CARSENTIETESSE H; FARINOTTI R; DURANT J; ROGER PM; DESALVADOR F; BERNARD E; ROUVEIX B; DELLAMONICA P
      PHARMACOKINETIC PARAMETERS AND KILLING RATES IN SERUM OF VOLUNTEERS RECEIVING AMOXICILLIN, CEFADROXIL OR CEFIXIME ALONE OR ASSOCIATED WITH NIFLUMIC ACID OR PARACETAMOL

      European journal of drug metabolism and pharmacokinetics
    34. CRAUSTEMANCIET S; BROSSARD D; DECROIX MO; FARINOTTI R; CHAUMEIL JC
      CEFPODOXIME-PROXETIL PROTECTION FROM INTESTINAL LUMEN HYDROLYSIS BY OIL-IN-WATER SUBMICRON EMULSIONS

      International journal of pharmaceutics
    35. VATIER J; CELICEPINGAUD C; FARINOTTI R
      A COMPUTERIZED ARTIFICIAL STOMACH MODEL TO ASSESS SODIUM ALGINATE-INDUCED PH GRADIENT

      International journal of pharmaceutics
    36. MASSIAS L; MULLERSERIEYS C; FARINOTTI R; BERGOGNEBEREZIN E
      PHARMACOKINETICS OF CEFUROXIME IN HEALTHY-VOLUNTEERS - AN UPDATE

      Journal of antimicrobial chemotherapy
    37. NOUAILLEDEGORCE B; VEAU C; DAUTREY S; TOD M; LAOUARI D; CARBON C; FARINOTTI R
      INFLUENCE OF RENAL-FAILURE ON CIPROFLOXACIN PHARMACOKINETICS IN RATS

      Antimicrobial agents and chemotherapy
    38. JOINLAMBERT O; MAINARDI JL; CUVELIER C; DAUTREY S; FARINOTTI R; FANTIN B; CARBON C
      CRITICAL IMPORTANCE OF IN-VIVO AMOXICILLIN AND CEFOTAXIME CONCENTRATIONS FOR SYNERGY IN TREATMENT OF EXPERIMENTAL ENTEROCOCCUS-FAECALIS ENDOCARDITIS

      Antimicrobial agents and chemotherapy
    39. POSHO L; DELBOSBOCAGE L; GUEYLARD D; FARINOTTI R; CARBON C
      EFFECTS OF SALMONELLA-TYPHIMURIUM INFECTION AND OFLOXACIN TREATMENT ON GLUCOSE AND GLUTAMINE-METABOLISM IN CACO-2 TC-7 CELLS/

      Antimicrobial agents and chemotherapy
    40. Vatier, J; Celice-Pingaud, C; Farinotti, R
      In vitro evaluation of the antacid activity of Saint-Yorre and Vichy Celestins mineral waters in the << artificial stomach-duodenum >> model.

      ANNALES DE GASTROENTEROLOGIE ET D HEPATOLOGIE
    41. WOLKENSTEIN P; BAUDCAMUS F; LECOEUR S; POVEDA JD; FARINOTTI R; BEAUNE P; ELIASZEWICZ M; CHOSIDOW O
      ACQUISITION OF A SLOW ACETYLATOR PHENOTYPE IN AIDS PATIENTS WITH A RAPID ACETYLATOR GENOTYPE - AN EXPLANATION FOR HIGH-FREQUENCY OF CUTANEOUS SULFONAMIDES REACTIONS IN AIDS

      Journal of investigative dermatology
    42. CUVELIER AC; BERLIOZ F; DAUTREY SC; ROZE C; CARBON C; FARINOTTI R
      INTESTINAL-ABSORPTION OF SAQUINAVIR IN THE RAT - INSIGHTS IN POSSIBLEMECHANISMS

      Gastroenterology
    43. LANGOUET AM; SIMON D; BRICE P; REYES F; SALLES G; TILLY H; FARINOTTI R; FAURE P; LEPAGE E; GISSELBRECHT C
      FACTORS INFLUENCING HEMATOLOGIC RECOVERY AFTER PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION IN AGGRESSIVE NON-HODGKINS-LYMPHOMA

      British Journal of Haematology
    44. FARINOTTI R; FERRARINI M; SOLARI A; FILIPPINI G
      INCIDENCE AND SURVIVAL OF CHILDHOOD CNS TUMORS IN THE REGION OF LOMBARDY, ITALY

      Brain (Print)
    45. DUCHARME J; FARINOTTI R
      RAPID AND SIMPLE METHOD TO DETERMINE CHLOROQUINE AND ITS DESETHYLATEDMETABOLITES IN HUMAN MICROSOMES BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH FLUORESCENCE DETECTION

      Journal of chromatography B. Biomedical sciences and applications
    46. VATIER J; CAI S; CELICEPINGAUD C; LENOT P; GLEIZES S; TOSELLI D; FARINOTTI R
      INTEREST OF THE ARTIFICIAL STOMACH-DUODENUM MODEL FOR IN-VITRO EVALUATION OF THE ACTIVITY OF ENZYMES CONTAINED IN GALENIC FORMS

      STP pharma sciences
    47. GIMENEZ F; SOURSAC M; FARINOTTI R
      ENANTIOMERIC SEPARATION OF 5 AMINO-ACIDS BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY ON A CHIRAL CROWN-ETHER COLUMN

      Chirality
    48. CRAUSTEMANCIET S; DECROIX MO; FARINOTTI R; CHAUMEIL JC
      CEFPODOXIME-PROXETIL HYDROLYSIS AND FOOD EFFECTS IN THE INTESTINAL LUMEN BEFORE ABSORPTION - IN-VITRO COMPARISON OF RABBIT AND HUMAN MATERIAL

      International journal of pharmaceutics
    49. CRAUSTEMANCIET S; HUNEAU JF; DECROIX MO; TOME D; FARINOTTI R; CHAUMEIL JC
      CEFPODOXIME PROXETIL ESTERASE-ACTIVITY IN RABBIT SMALL-INTESTINE - A ROLE IN THE PARTIAL CEFPODOXIME ABSORPTION

      International journal of pharmaceutics
    50. SOGNI P; HADENGUE A; MOREAU R; LEMOINE O; SOUPISON T; OBERTI F; FARINOTTI R; LEBREC D
      ACUTE EFFECTS OF PROPYLTHIOURACIL ON HEMODYNAMICS AND OXYGEN-CONTENT IN PATIENTS WITH ALCOHOLIC CIRRHOSIS

      Journal of hepatology
    51. RABBAA L; DAUTREY S; COLASLINHART N; CARBON C; FARINOTTI R
      ABSORPTION OF OFLOXACIN ISOMERS IN THE RAT SMALL-INTESTINE

      Antimicrobial agents and chemotherapy
    52. BAUDRY S; PHAM YT; BAUNE B; VIDREQUIN S; CREVOISIER C; GIMENEZ F; FARINOTTI R
      STEREOSELECTIVE PASSAGE OF MEFLOQUINE THROUGH THE BLOOD-BRAIN-BARRIERIN THE RAT

      Journal of Pharmacy and Pharmacology
    53. HARCOUET L; LEBREC D; ROZE C; CARBON C; FARINOTTI R
      INCREASED INTESTINAL-ABSORPTION OF CEFIXIME BY NIFEDIPINE IN THE RAT INTESTINAL PERFUSION MODEL - EVIDENCE FOR A NEURAL REGULATION

      The Journal of pharmacology and experimental therapeutics
    54. BERLIOZ F; JULIEN S; TSOCAS A; CHARIOT J; ROZE C; FARINOTTI R
      NEURAL MODULATION OF JEJUNAL-ABSORPTION OF THE PEPTIDOMIMETIC DRUG CEPHALEXIN IN THE RAT

      Gastroenterology
    55. VEYRATFOLLET C; FARINOTTI R; PALMER JL
      PHYSIOLOGY OF CHEMOTHERAPY-INDUCED EMESIS AND ANTIEMETIC THERAPY - PREDICTIVE MODELS FOR EVALUATION OF NEW COMPOUNDS

      Drugs
    56. DUCHARME J; FLINOIS JP; BAUNE B; FARINOTTI R; BEAUNE P
      MIDAZOLAM (MDZ) HYDROXYLATION IN YEAST-EXPRESSED CYPS

      Clinical pharmacology and therapeutics
    57. BOUGEOIS B; SERVIN F; MASSIAS L; FARINOTTI R; DESMONTS JM
      A PHARMACOKINETIC AND DYNAMIC STUDY OF PROPOFOL INFUSION IN ALCOHOLICPATIENTS

      Anesthesiology
    58. SERVIN F; LAVAUT E; PEYTAVIN G; FARINOTTI R; DESMONTS JM
      A PHARMACOKINETIC AND DYNAMIC STUDY OF MIVACURIUM INFUSION IN ELDERLYPATIENTS

      Anesthesiology
    59. DUCHARME J; FERNANDEZ C; GIMENEZ F; FARINOTTI R
      CRITICAL ISSUES IN CHIRAL DRUG ANALYSIS IN BIOLOGICAL-FLUIDS BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY

      Journal of chromatography B. Biomedical applications
    60. BRUNPASCAUD M; CHAU F; GARRY L; FARINOTTI R; DEROUIN F; GIRARD PM
      ALTERED TRIMETHOPRIM-SULFAMETHOXAZOLE RATIOS FOR PROPHYLAXIS AND TREATMENT OF TOXOPLASMA-GONDII AND PNEUMOCYSTIS-CARINII DUAL INFECTIONS INRAT MODEL

      Journal of acquired immune deficiency syndromes and human retrovirology
    61. VATIER J; RIQUET W; CELICEPINGAUD C; OLIVIER A; MIGNON M; FARINOTTI R
      EFFECT ON GASTRIC-SECRETION, GASTRIN AND HISTAMINE-RELEASE DURING ANDAFTER LONG-TERM TREATMENT BY PIRENZEPINE IN DOGS

      Fundamental and clinical pharmacology
    62. FAURISSON F; DESSANGES JF; GRIMFELD A; BEAULIEU R; KITZIS MD; PEYTAVIN G; LEFEVRE JP; FARINOTTI R; SAUTEGEAU A
      PERFORMANCES AND ERGONOMICS OF NEBULIZERS IN CYSTIC-FIBROSIS

      Revue des maladies respiratoires
    63. DUCHARME J; FARINOTTI R
      CLINICAL PHARMACOKINETICS AND METABOLISM OF CHLOROQUINE - FOCUS ON RECENT ADVANCEMENTS

      Clinical pharmacokinetics
    64. VIDREQUIN S; GIMENEZ F; BASCO LK; MARTIN C; LEBRAS J; FARINOTTI R
      UPTAKE OF MEFLOQUINE ENANTIOMERS INTO UNINFECTED AND MALARIA-INFECTEDERYTHROCYTES

      Drug metabolism and disposition
    65. ROMAND S; DELLABRUNA C; FARINOTTI R; DEROUIN F
      IN-VITRO AND IN-VIVO EFFECTS OF RIFABUTIN ALONE OR COMBINED WITH ATOVAQUONE AGAINST TOXOPLASMA-GONDII

      Antimicrobial agents and chemotherapy
    66. RABBAA L; DAUTREY S; COLASLINHART N; CARBON C; FARINOTTI R
      INTESTINAL ELIMINATION OF OFLOXACIN ENANTIOMERS IN THE RAT - EVIDENCEOF A CARRIER-MEDIATED PROCESS

      Antimicrobial agents and chemotherapy
    67. GANGNEUX JP; SULAHIAN A; GARIN YJF; FARINOTTI R; DEROUIN F
      THERAPY OF VISCERAL LEISHMANIASIS DUE TO LEISHMANIA-INFANTUM - EXPERIMENTAL ASSESSMENT OF EFFICACY OF AMBISOME

      Antimicrobial agents and chemotherapy
    68. FANTIN B; PIERRE J; CASTELAPAPIN N; SAINTJULIEN L; DRUGEON H; FARINOTTI R; CARBON C
      IMPORTANCE OF PENICILLINASE PRODUCTION FOR ACTIVITY OF PENICILLIN ALONE OR IN COMBINATION WITH SULBACTAM IN EXPERIMENTAL ENDOCARDITIS DUE TO METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS

      Antimicrobial agents and chemotherapy
    69. DESLANDES A; CAMUS F; LACROIX C; CARBON C; FARINOTTI R
      EFFECTS OF NIFEDIPINE AND DILTIAZEM ON PHARMACOKINETICS OF CEFPODOXIME FOLLOWING ITS ORAL-ADMINISTRATION

      Antimicrobial agents and chemotherapy
    70. CHEMLAL K; SAINTJULIEN L; JOLY V; FARINOTTI R; SETA N; YENI P; CARBON C
      COMPARISON OF FLUCONAZOLE AND AMPHOTERICIN-B FOR TREATMENT OF EXPERIMENTAL CANDIDA-ALBICANS ENDOCARDITIS IN RABBITS

      Antimicrobial agents and chemotherapy
    71. VATIER J; CAI S; SLAMA A; FARINOTTI R
      ANTACID ACTIVITY OF CITRATE-BICARBONATE C OMPLEX OF EFFERVESCENT FORMULATIONS OF RANITIDINE, IN-VITRO EVALUATION USING THE ARTIFICIAL STOMACH-DUODENUM MODEL

      Therapie
    72. VATIER J; CAI S; CELICEPINGAUD C; CASTELAPAPIN N; MIGNON M; FARINOTTI R
      IN-VITRO ASSESSMENT OF ANTACID EFFICACY USING A COMPUTER-CONTROLLED ARTIFICIAL STOMACH-DUODENUM MODEL REPRODUCING GASTRODUODENAL FLUX REGULATION

      Therapie
    73. BOURAHLA A; MARTIN C; GIMENEZ F; SINGHASIVANON V; ATTANATH P; SABCHEARON A; CHONGSUPHAJAISIDDHI T; FARINOTTI R
      STEREOSELECTIVE PHARMACOKINETICS OF MEFLOQUINE IN YOUNG-CHILDREN

      European Journal of Clinical Pharmacology
    74. DELARMINAT V; BOCZKOWSKI J; DUREUIL B; VICAUT E; FARINOTTI R; AUBIER M; DESMONTS JM
      ROLE OF PROSTAGLANDINS AND NITRIC-OXIDE ON HALOTHANE-INDUCED ARTERIOLAR DILATATION IN RAT DIAPHRAGM

      British Journal of Anaesthesia
    75. MURAT I; BILLARD V; VERNOIS J; ZAOUTER M; MARSOL P; SOURON R; FARINOTTI R
      PHARMACOKINETICS OF PROPOFOL AFTER A SINGLE-DOSE IN CHILDREN AGED 1-3YEARS WITH MINOR BURNS - COMPARISON OF 3 DATA-ANALYSIS APPROACHES

      Anesthesiology
    76. NATTOUF H; DAVRINCHE C; SINET M; FARINOTTI R
      HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ASSAY FOR 3'-AMINO-3'-DEOXYTHYMIDINE IN PLASMA, WITH 9-FLUORENYL METHYL CHLOROFORMATE AS THE DERIVATIZATION AGENT

      Journal of chromatography B. Biomedical applications
    77. FERNANDEZ C; GIMENEZ F; MAYRARGUE J; THUILLIER A; FARINOTTI R
      DEGRADATION AND RACEMIZATION OF ZOPICLONE ENANTIOMERS IN PLASMA AND PARTIALLY AQUEOUS-SOLUTIONS

      Chirality
    78. FERNANDEZ C; MARTIN C; GIMENEZ F; FARINOTTI R
      CLINICAL PHARMACOKINETICS OF ZOPICLONE

      Clinical pharmacokinetics
    79. FAURISSON F; DESSANGES JF; GRIMFELD A; BEAULIEU R; KITZIS MD; PEYTAVIN G; LEFEBVRE JP; FARINOTTI R; SAUTEGEAU A
      NEBULIZER PERFORMANCE - AFLM STUDY

      Respiration
    80. PEYTAVIN G; FARINOTTI R; REVUZ J; ROUJEAU JC; CHOSIDOW O
      NORMAL PLASMATIC LEVELS OF SULFONAMIDES IN SULFONAMIDE-INDUCED STEVENS-JOHNSON SYNDROME AND TOXIC EPIDERMAL NECROLYSIS

      Journal of investigative dermatology
    81. NGUYEN HN; LOUVILLE Y; FARINOTTI R; CAZALAA JB; ATINAULT A; TROUVIN JH; BAILLET A; COSTE JL; BARRIER G
      USING SUBDELTA WAVES TO GUIDE PROPOFOL INFUSION

      Anesthesiology
    82. MURAT I; ZAOUTER M; GRANADOS M; SOURON R; FARINOTTI R
      PHARMACOKINETICS OF PROPOFOL CHILDREN UNDER 3 YEARS OF AGE

      Anesthesiology
    83. CAMUS F; DESLANDES A; HARCOUET L; FARINOTTI R
      HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC METHOD FOR THE DETERMINATION OF CEFPODOXIME LEVELS IN PLASMA AND SINUS MUCOSA

      Journal of chromatography B. Biomedical applications
    84. FANTIN B; FARINOTTI R; THABAUT A; CARBON C
      CONDITIONS FOR THE EMERGENCE OF RESISTANCE TO CEFPIROME AND CEFTAZIDIME IN EXPERIMENTAL ENDOCARDITIS DUE TO PSEUDOMONAS-AERUGINOSA

      Journal of antimicrobial chemotherapy
    85. BASCO LK; PEYTAVIN G; GIMENEZ F; GENISSEL B; FARINOTTI R; LEBRAS J
      IN-VITRO ACTIVITY OF THE ENANTIOMERS OF N-DESBUTYL DERIVATIVE OF HALOFANTRINE

      Tropical medicine and parasitology
    86. JOLY V; FARINOTTI R; SAINTJULIEN L; CHERON M; CARBON C; YENI P
      IN-VITRO RENAL TOXICITY AND IN-VIVO THERAPEUTIC EFFICACY IN EXPERIMENTAL MURINE CRYPTOCOCCOSIS OF AMPHOTERICIN-B (FUNGIZONE) ASSOCIATED WITH INTRALIPID

      Antimicrobial agents and chemotherapy
    87. MARTIN C; GIMENEZ F; BANGCHANG KN; KARBWANG J; WAINER IW; FARINOTTI R
      WHOLE-BLOOD CONCENTRATIONS OF MEFLOQUINE ENANTIOMERS IN HEALTHY THAI VOLUNTEERS

      European Journal of Clinical Pharmacology
    88. GIMENEZ F; GILLOTIN C; BASCO LK; BOUCHAUD O; AUBRY AF; WAINER IW; LEBRAS J; FARINOTTI R
      PLASMA-CONCENTRATIONS OF THE ENANTIOMERS OF HALOFANTRINE AND ITS MAINMETABOLITE IN MALARIA PATIENTS

      European Journal of Clinical Pharmacology
    89. VATIER J; HARMAN A; CASTELA N; DROYLEFAIX MT; FARINOTTI R
      INTERACTIONS OF CIMETIDINE AND RANITIDINE WITH ALUMINUM-CONTAINING ANTACIDS AND A CLAY-CONTAINING GASTRIC-PROTECTIVE DRUG IN AN ARTIFICIAL STOMACH-DUODENUM MODEL

      Journal of pharmaceutical sciences
    90. GIMENEZ F; PENNIE RA; KOREN G; CREVOISIER C; WAINER IW; FARINOTTI R
      STEREOSELECTIVE PHARMACOKINETICS OF MEFLOQUINE IN HEALTHY CAUCASIANS AFTER MULTIPLE DOSES

      Journal of pharmaceutical sciences
    91. MAINARDI JL; ZHOU XY; GOLDSTEIN F; MOHLER J; FARINOTTI R; GUTMANN L; CARBON C
      ACTIVITY OF ISEPAMICIN AND SELECTION OF PERMEABILITY MUTANTS TO BETA-LACTAMS DURING AMINOGLYCOSIDE THERAPY OF EXPERIMENTAL ENDOCARDITIS DUETO KLEBSIELLA-PNEUMONIAE-CF104 PRODUCING AN AMINOGLYCOSIDE ACETYLTRANSFERASE 6' MODIFYING ENZYME AND A TEM-3 BETA-LACTAMASE

      The Journal of infectious diseases
    92. RUBINSTEIN E; STJULIEN L; RAMON J; DAUTREY S; FARINOTTI R; HUNEAU JF; CARBON C
      THE INTESTINAL ELIMINATION OF CIPROFLOXACIN IN THE RAT

      The Journal of infectious diseases
    93. MASSIAS L; BUFFE P; COHEN B; CUDENNEC Y; GEHANNO P; STERKERS O; FARINOTTI R
      STUDY OF THE DISTRIBUTION OF ORAL CIPROFLOXACIN INTO THE MUCOSA OF THE MIDDLE-EAR AND THE CORTICAL BONE OF THE MASTOID PROCESS

      Chemotherapy
    94. FASSOULAKI A; FARINOTTI R; MANTZ J; DESMONTS JM
      DOES TOLERANCE DEVELOP TO THE ANESTHETIC EFFECTS OF PROPOFOL IN RATS

      British Journal of Anaesthesia
    95. VEYSSIER P; CEVALLOS R; FOUILLERIBEYRE CL; GEFFRAY L; KALOUSTIAN E; FARINOTTI R
      SAFETY OF PENTAMIDINE PROPHYLAXIS FOR PNEUMOCYSTIS-CARINII PNEUMONIA ON THE ENDOCRINE PANCREATIC FUNCTION IN HIV PATIENTS

      Annales de medecine interne
    96. BOUCHAUD O; BASCO LK; GILLOTIN C; GIMENEZ F; RAMILIARISOA O; GENISSEL B; BOUVET E; FARINOTTI R; LEBRAS J; COULAUD JP
      CLINICAL EFFICACY AND PHARMACOKINETICS OF MICRONIZED HALOFANTRINE FORTHE TREATMENT OF ACUTE UNCOMPLICATED FALCIPARUM-MALARIA IN NONIMMUNE PATIENTS

      The American journal of tropical medicine and hygiene
    97. BINGEN E; DOIT C; FARINOTTI R; LAMBERTZECHOVSKY N
      KILLING KINETICS OF CEFUROXIME AGAINST STREPTOCOCCUS-PNEUMONIAE IN ANINVITRO MODEL SIMULATING SERUM CONCENTRATION PROFILES AFTER INTRAMUSCULAR ADMINISTRATION

      European journal of clinical microbiology & infectious diseases
    98. PEYTAVIN G; GIMENEZ F; GENISSEL B; GILLOTIN C; BAILLET A; WAINER IW; FARINOTTI R
      CHIRAL RESOLUTION OF SOME ANTIMALARIAL AGENTS BY SUBCRITICAL AND SUPERCRITICAL-FLUID CHROMATOGRAPHY ON AN (S)-NAPHTHYLUREA STATIONARY-PHASE

      Chirality
    99. CHOSSON E; UZAN S; GIMENEZ F; WAINER IW; FARINOTTI R
      INFLUENCE OF SPECIFIC ALBUMIN LIGAND MARKERS USED AS MODIFIERS ON THESEPARATION OF BENZODIAZEPINE ENANTIOMERS BY CHIRAL LIQUID-CHROMATOGRAPHY ON A HUMAN SERUM-ALBUMIN COLUMN

      Chirality
    100. MASSIAS L; BUFFE P; COHEN B; CUDENNEC Y; GEHANNO P; STERKERS O; FARINOTTI R
      ORAL CIPROFLOXACIN DIFFUSION INTO MIDDLE- EAR MUCOSA AND MASTOID CORTICAL BONE

      Medecine et maladies infectieuses


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 27/01/21 alle ore 08:32:35